Ironwood Pharmaceuticals, Inc. (IRWD)

Ironwood Pharmaceuticals, Inc. (IRWD) is a healthcare company (drug manufacturers - specialty & generic) based in the United States. The share price is $4.87, up 0.41% on the day, which values the company at $806.23M. Price as of 18 Nov 2026, 10:38 UTC, from Yahoo Finance.

Key facts

Share price
$4.87+0.41% today
Market value
$806.23M
P/E ratio
5.4×last 12 months
Forward P/E
3.1×
Funk Score
49/100
Against its own history
Well below its usual priceusual price $8.48
200-week average
$5.7615% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Ironwood Pharmaceuticals, Inc. in more detail

IRWD trades at 5.4× its last twelve months' earnings, 3.1× next year's expected earnings, 2.0× sales. Measured against its own history, the price is 43% below what its usual multiples would imply ($8.48) — well below its usual price. It sits 15% below its 200-week average of $5.76.

Over the last five fiscal years Ironwood Pharmaceuticals, Inc. has compounded revenue -5.3% a year, earnings per share -25.6% a year, free cash flow -5.3% a year. Its Funk Score is 49 out of 100 (financial strength 2.3, profitability 7.2, growth 0.8, value 9.4, each out of 10).

In its favour: High return on invested capital. Worth checking: Altman Z in the distress zone.

Ironwood Pharmaceuticals, Inc. (IRWD): questions and answers

What is IRWD's P/E ratio?

Ironwood Pharmaceuticals, Inc. trades at 5.4× its last twelve months' earnings and 3.1× next year's expected earnings. At its fiscal year-ends over the past 6 years the P/E ranged from 3.6× to 443.0×, with a median of 19.9×.

What is Ironwood Pharmaceuticals, Inc.'s market cap?

Ironwood Pharmaceuticals, Inc. is valued at $806.23M at a share price of $4.87.

Is IRWD overvalued or undervalued?

Against its own history, IRWD is well below its usual price: the price is 43% below the $8.48 implied by the median multiples it has traded at (price / earnings, price / sales, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is IRWD above its 200-week moving average?

No. IRWD is 15.5% below its 200-week average of $5.76. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Ironwood Pharmaceuticals, Inc. growing?

Over the last five fiscal years Ironwood Pharmaceuticals, Inc.'s revenue grew -5.3% a year and its earnings per share -25.6% a year; over ten years revenue grew 7.1% a year.

Does IRWD pay a dividend?

Ironwood Pharmaceuticals, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Ironwood Pharmaceuticals, Inc. (IRWD) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/IRWD

Underlying data: Yahoo Finance; company filings with the SEC.